These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 12584574)
1. NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers. Hesson L; Dallol A; Minna JD; Maher ER; Latif F Oncogene; 2003 Feb; 22(6):947-54. PubMed ID: 12584574 [TBL] [Abstract][Full Text] [Related]
2. RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1. Tommasi S; Dammann R; Jin SG; Zhang XF; Avruch J; Pfeifer GP Oncogene; 2002 Apr; 21(17):2713-20. PubMed ID: 11965544 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers. Agathanggelou A; Dallol A; Zöchbauer-Müller S; Morrissey C; Honorio S; Hesson L; Martinsson T; Fong KM; Kuo MJ; Yuen PW; Maher ER; Minna JD; Latif F Oncogene; 2003 Mar; 22(10):1580-8. PubMed ID: 12629521 [TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma. Chow LS; Lo KW; Kwong J; Wong AY; Huang DP Oncol Rep; 2004 Oct; 12(4):781-7. PubMed ID: 15375500 [TBL] [Abstract][Full Text] [Related]
5. CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations. Hesson LB; Wilson R; Morton D; Adams C; Walker M; Maher ER; Latif F Oncogene; 2005 Jun; 24(24):3987-94. PubMed ID: 15806169 [TBL] [Abstract][Full Text] [Related]
6. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas. Hesson L; Bièche I; Krex D; Criniere E; Hoang-Xuan K; Maher ER; Latif F Oncogene; 2004 Mar; 23(13):2408-19. PubMed ID: 14743209 [TBL] [Abstract][Full Text] [Related]
7. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours. Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729 [TBL] [Abstract][Full Text] [Related]
8. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Dammann R; Li C; Yoon JH; Chin PL; Bates S; Pfeifer GP Nat Genet; 2000 Jul; 25(3):315-9. PubMed ID: 10888881 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma. Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917 [TBL] [Abstract][Full Text] [Related]
11. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536 [TBL] [Abstract][Full Text] [Related]
12. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma. Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío I; Castresana JS BMC Cancer; 2006 Oct; 6():254. PubMed ID: 17064406 [TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Dammann R; Yang G; Pfeifer GP Cancer Res; 2001 Apr; 61(7):3105-9. PubMed ID: 11306494 [TBL] [Abstract][Full Text] [Related]
14. The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas. Dammann R; Takahashi T; Pfeifer GP Oncogene; 2001 Jun; 20(27):3563-7. PubMed ID: 11429703 [TBL] [Abstract][Full Text] [Related]
15. Nore1 inhibits tumor cell growth independent of Ras or the MST1/2 kinases. Aoyama Y; Avruch J; Zhang XF Oncogene; 2004 Apr; 23(19):3426-33. PubMed ID: 15007383 [TBL] [Abstract][Full Text] [Related]
16. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma. Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277 [TBL] [Abstract][Full Text] [Related]
17. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients. Honorio S; Agathanggelou A; Schuermann M; Pankow W; Viacava P; Maher ER; Latif F Oncogene; 2003 Jan; 22(1):147-50. PubMed ID: 12527916 [TBL] [Abstract][Full Text] [Related]
18. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038 [TBL] [Abstract][Full Text] [Related]
19. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers. Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551 [TBL] [Abstract][Full Text] [Related]
20. The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma. Geli J; Kiss N; Lanner F; Foukakis T; Natalishvili N; Larsson O; Kogner P; Höög A; Clark GJ; Ekström TJ; Bäckdahl M; Farnebo F; Larsson C Endocr Relat Cancer; 2007 Mar; 14(1):125-34. PubMed ID: 17395981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]